CD Biosynsis offers accelerated Saccharomyces cerevisiae Strain Development and Screening Services, utilizing advanced genetic tools and high-throughput platforms to significantly speed up the optimization cycle for this eukaryotic host. Saccharomyces cerevisiae (baker's yeast) is the premier eukaryotic chassis for producing complex molecules, including therapeutic proteins, advanced biofuels, and specialty chemicals, due to its robust growth, fermentation capabilities, and natural post-translational modification (PTM) machinery. Our services combine high-precision genome editing (CRISPR-Cas9, Base Editing) with automated High-Throughput Screening (HTS) technologies to quickly generate, evaluate, and optimize thousands of genetic variants. We specialize in engineering Saccharomyces cerevisiae for enhanced yield, improved tolerance to industrial stressors, and efficient utilization of diverse feedstocks, providing a fast track from concept to commercial-ready production strain.
Get a QuoteStrain development in Saccharomyces cerevisiae often involves complex, sequential genomic modifications (Build) followed by labor-intensive fermentation and analysis (Test). Our integrated platform addresses this by maximizing the efficiency of both stages. We leverage the host's robust Homology-Directed Repair (HDR) pathway for rapid, multiplexed genomic edits, and couple this with automated liquid handling and miniaturized culture formats for screening thousands of engineered clones. This integration accelerates the iterative cycle, translating rational designs into high-performing production strains faster than conventional methods.
CRISPR-Cas9 Editing
Used for large chromosomal knock-ins (KI) of pathways and clean gene knockouts (KO), leveraging Saccharomyces cerevisiae's highly efficient Homology-Directed Repair (HDR).
Base Editing (BE)
For high-precision, single-nucleotide substitutions to fine-tune regulatory elements (promoters/RBS) or optimize enzyme function without DSBs.
Multiplex Assembly
Technology enabling the simultaneous integration of multiple gene cassettes or the deletion of multiple genes in a single transformation step in Saccharomyces cerevisiae.
Automated Microplate Culture
Using 96- or 384-well plates with automated liquid handling and robotic incubation for high-density strain library cultivation, monitoring growth and productivity simultaneously.
Fluorescence-Activated Cell Sorting (FACS)
Advanced screening for libraries linked to fluorescent reporters or biosensors, enabling the ultra-high-throughput selection of the highest-producing Saccharomyces cerevisiae cells.
Advanced Sensor Assays
Implementation of biosensors or coupled enzyme assays for the rapid, real-time detection and quantification of target products directly in the culture media, tailored for yeast metabolism.
Pathway Installation & PTM
Stable chromosomal insertion of complete heterologous biosynthetic pathways, ensuring correct eukaryotic protein folding and post-translational modifications.
Host Tolerance Engineering
Modifying the strain to enhance tolerance to solvents, low pH, or high product titers commonly found in large-scale Saccharomyces cerevisiae fermentation.
Feedstock Utilization
Engineering the host to efficiently utilize non-native, low-cost carbon sources (e.g., xylose, arabinose, lignocellulose derivatives) by inserting heterologous transporters and pathways.
Integrated cycle for rapid, iterative strain optimization using advanced tools.
1. Rational Design & Library Generation
2. Genomic Modification (Build)
3. High-Throughput Screening (Test)
4. Data Analysis & Iteration (Learn)
Computational modeling identifies optimal genetic modifications (KO, KI, tuning) and designs the editing strategy.
Design gRNAs/primers and construct large synthetic DNA libraries (e.g., promoter or RBS variants).
Select appropriate chromosomal integration sites for stable insertion.
Construct high-diversity strain libraries using CRISPR tools (Cas9, BE, CRISPRi).
Execute multiplexed gene editing and stable chromosomal pathway integration in Saccharomyces cerevisiae.
Verify genotype of the initial library population.
Analyze HTS data to correlate genotype with desired phenotype (yield/growth).
Refine the metabolic model and calculate the next, more focused set of genetic edits.
Deliver the final optimized Saccharomyces cerevisiae production strain.
High Efficiency HDR
Leveraging the yeast's intrinsic, robust Homology-Directed Repair (HDR) system ensures stable, clean, and multiplexed chromosomal integration of large biosynthetic pathways (Knock-in).
Eukaryotic Fidelity
The Saccharomyces cerevisiae chassis provides native folding, PTM, and compartmentalization machinery essential for complex pathway optimization and functional protein production.
Integrated HTS Platform
Automated HTS systems are specifically adapted for Saccharomyces cerevisiae to quickly screen large libraries (millions of cells), accelerating the Test phase of the optimization cycle.
Stable Chromosomal Integration
All final optimized pathways are stably integrated into the Saccharomyces cerevisiae chromosome, guaranteeing genetic stability during large-scale industrial fermentation.
Still have questions?
Contact Us1. Why is Saccharomyces cerevisiae preferred for developing complex pathways?
As a eukaryotic host, Saccharomyces cerevisiae provides organelles and PTM machinery essential for correctly assembling and folding multi-enzyme pathways, especially those producing large, complex molecules.
2. How does the host's HDR system accelerate strain development?
The host's highly efficient Homology-Directed Repair (HDR) mechanism allows for precise, clean gene knockouts and stable integration of large DNA cassettes (knock-ins) in a single step, minimizing the risk of random integration.
3. What kind of libraries can you screen using your HTS platform?
We screen high-diversity libraries, including promoter strength libraries, Ribosome Binding Site (RBS) variant libraries, and multi-locus CRISPRi libraries for optimal repression levels.
4. How does FACS (Fluorescence-Activated Cell Sorting) aid screening?
FACS is used to rapidly sort millions of cells. By linking pathway flux to a fluorescent reporter, we can isolate the top 0.1% of high-producing Saccharomyces cerevisiae cells from a large library in minutes, accelerating the Test phase.
5. Can you engineer the host to utilize xylose or other non-standard sugars?
Yes. A common optimization target is to integrate heterologous genes (e.g., xylose isomerase) that enable Saccharomyces cerevisiae to efficiently consume non-standard, low-cost carbon sources from biomass hydrolysates.
6. Why is chromosomal integration preferred over plasmid use for final strains?
Chromosomal integration eliminates the issues of plasmid loss and variable copy number, ensuring stable and consistent expression of the optimized pathway during large-scale, long-duration industrial fermentation runs.
7. What input materials are needed to start a strain development project?
We require the target chemical product, the biosynthetic pathway genes (or sequence information), and the Saccharomyces cerevisiae host strain to be modified.
8. What is included in the final delivery package?
The final delivery includes the optimized Saccharomyces cerevisiae production strain, a detailed report with all HTS data, genetic modifications, and performance metrics (e.g., titer and yield).
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.